Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

No­vo Nordisk said Thurs­day that it plans to even­tu­al­ly halt all of its hu­man in­sulin pen pro­duc­tion glob­al­ly, ...

Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Unfortunately, scammers have taken note of the high demand for GLP-1 medications, leading to a significant increase in ...

A doctor and honorary researcher at the University of Exeter is leading a campaign to make reusable insulin pens the standard ...

Counterfeit Ozempic pens, which appear to be relabelled insulin pens, have been detected in Australia and have caused a ...

We examine how to create a brand mood board – what they are, why they matter and how to make boards that capture the essence of your brand. Have you considered how the best brands can create a ...

It also captures information including insulin brand, insulin dose measurement, injection date and time, and the temperature of the insulin pen at the time of injection, all of which are viewable ...